[(18)F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers

OBJECTIVE: To assess the [(18)F]flortaucipir binding distribution across MAPT mutations in presymptomatic and symptomatic carriers. METHODS: We compared regional [(18)F]flortaucipir binding potential (BP(ND)) derived from a 130-minute dynamic [(18)F]flortaucipir PET scan in 9 (pre)symptomatic MAPT m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolters, Emma E., Papma, Janne M., Verfaillie, Sander C.J., Visser, Denise, Weltings, Emma, Groot, Colin, van der Ende, Emma L., Giannini, Lucia A.A., Tuncel, Hayel, Timmers, Tessa, Boellaard, Ronald, Yaqub, Maqsood, van Assema, Danielle M.E., Kuijper, Dennis A., Segbers, Marcel, Rozemuller, Annemieke J.M., Barkhof, Frederik, Windhorst, Albert D., van der Flier, Wiesje M., Pijnenburg, Yolande A.L., Scheltens, Philip, van Berckel, Bart N.M., van Swieten, John C., Ossenkoppele, Rik, Seelaar, Harro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448551/
https://www.ncbi.nlm.nih.gov/pubmed/34210823
http://dx.doi.org/10.1212/WNL.0000000000012448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448551/
https://www.ncbi.nlm.nih.gov/pubmed/34210823
http://dx.doi.org/10.1212/WNL.0000000000012448

Ejemplares similares